Leading colorectal cancer expert from Oxford discusses targeted chemotherapy progress in colorectal cancer treatment.
Going from 5-fluorouracil to anti-angiogenesis medications. Which patients benefit most from targeted chemotherapy of colon cancer? How life expectancy has changed with new chemotherapy medications and treatment protocols? What patients should know about EGFR inhibitors in colon cancer treatment?